Abstracts (HTML) List of Authors

Aghaallaei, N

Altered extrinsic and intrinsic factors synergistically accelerate the thymic T-ALL development
Modelling congenital neutropenia, a pre-leukemic bone marrow failure syndrome in zebrafish
De novo design of growth factor inhibiting proteins

Albinger, N

Primary CD33-targeting CAR-NK cells for the treatment of acute myeloid leukemia

Alejo, O

Identifying gene targets for drug repurposing to preventing myeloid malignancies

Alexe, G

Breaking the pump: targeting the sodium-potassium pump as a therapeutic strategy in acute myeloid leukemia

Alten, J

Prognostic significance of minimal residual disease prior to reinduction in intermediate risk patients with ALL
Prognostic relevance of persisting minimal residual disease in children with ALL and slow early response to chemotherapy

Amaral, AT

An innovative tailored CAR-T cell-redirecting immunotherapy for the treatment of metastatic and refractory Ewing Sarcoma

Amend, D

Adapting CRISPR Cas9 dropout screens to in vivo PDX models of acute leukemias
Streamlining preclinical in vivo treatment trials by multiplexing genetically labelled PDX models in a single mouse
Mutations in KRAS and DNMT3A are not related to dependency in established tumors, in PDX acute leukemia model in vivo

Andrieux, G

Characterization of cooperating mechanisms in GATA2 syndrome
Identification of functional defects promoting leukemogenesis in GATA2-deficient individuals

Antunes, E

Understanding the role of ontogeny for the development of MLL-AF9 infant leukaemia

Armenteros-Monterroso, E

Establishing the mechanism for RUVBL2 essentiality in acute myeloid leukaemia

Ashtiani, M

Silencing the leukaemic fusion gene RUNX1/ETO by siRNA-loaded lipid nanoparticles restores myeloid differentiation
Epigenetic modifiers direct lineage switch in MLL-AF4 leukemia

Autenrieb, M-P

Modulation of Daratumumab efficacy by Decitabine in pediatric T-cell lymphoblastic leukemia (T-ALL)